re: chance of failing? avexa 754 on previous phase ll data achieved a 25 fold decrease in viral load on a non mutated hiv. (shire did this trial)
usually mutated is 2x as hard to kill
requires a 4 fold decrease in mutated HIV to pass phase ll
should be ok
- Forums
- ASX - By Stock
- flying high this week
re: chance of failing? avexa 754 on previous phase ll data...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online